Annual Working Capital
$220.65 M
+$55.86 M+33.90%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual working capital is currently $220.65 million, with the most recent change of +$55.86 million (+33.90%) on 31 December 2023. During the last 3 years, it has fallen by -$179.80 million (-44.90%). LGND annual working capital is now -80.06% below its all-time high of $1.11 billion, reached on 31 December 2019.LGND Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$284.62 M
-$9.08 M-3.09%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly working capital is currently $284.62 million, with the most recent change of -$9.08 million (-3.09%) on 30 September 2024. Over the past year, it has increased by +$46.35 million (+19.45%). LGND quarterly working capital is now -79.39% below its all-time high of $1.38 billion, reached on 31 March 2019.LGND Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.9% | +19.4% |
| 3 y3 years | -44.9% | -28.1% |
| 5 y5 years | -72.0% | -75.2% |
LGND Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.9% | +33.9% | -32.7% | +274.8% |
| 5 y | 5 years | -80.1% | +33.9% | -75.2% | +274.8% |
| alltime | all time | -80.1% | +315.8% | -79.4% | +275.8% |
Ligand Pharmaceuticals Incorporated Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $284.62 M(-3.1%) |
| June 2024 | - | $293.69 M(-16.3%) |
| Mar 2024 | - | $351.10 M(+59.1%) |
| Dec 2023 | $220.65 M(+33.9%) | $220.65 M(-7.4%) |
| Sept 2023 | - | $238.27 M(-3.7%) |
| June 2023 | - | $247.32 M(+7.9%) |
| Mar 2023 | - | $229.27 M(+39.1%) |
| Dec 2022 | $164.79 M(-61.1%) | $164.79 M(+93.4%) |
| Sept 2022 | - | $85.19 M(+12.2%) |
| June 2022 | - | $75.93 M(-67.5%) |
| Mar 2022 | - | $233.49 M(-44.8%) |
| Dec 2021 | $423.09 M(+5.7%) | $423.09 M(+6.9%) |
| Sept 2021 | - | $395.79 M(+10.4%) |
| June 2021 | - | $358.40 M(+4.9%) |
| Mar 2021 | - | $341.62 M(-14.7%) |
| Dec 2020 | $400.45 M(-63.8%) | $400.45 M(-50.9%) |
| Sept 2020 | - | $815.44 M(-2.3%) |
| June 2020 | - | $834.36 M(+3.0%) |
| Mar 2020 | - | $810.29 M(-26.8%) |
| Dec 2019 | $1.11 B(+40.4%) | $1.11 B(-3.6%) |
| Sept 2019 | - | $1.15 B(-13.9%) |
| June 2019 | - | $1.33 B(-3.5%) |
| Mar 2019 | - | $1.38 B(+75.2%) |
| Dec 2018 | $788.29 M(<-9900.0%) | $788.29 M(-17.2%) |
| Sept 2018 | - | $951.88 M(+12.3%) |
| June 2018 | - | $847.62 M(+730.4%) |
| Mar 2018 | - | $102.07 M(-5626.4%) |
| Dec 2017 | -$1.85 M(-97.1%) | -$1.85 M(-75.3%) |
| Sept 2017 | - | -$7.48 M(-73.9%) |
| June 2017 | - | -$28.66 M(-45.2%) |
| Mar 2017 | - | -$52.29 M(-18.4%) |
| Dec 2016 | -$64.08 M(+690.2%) | -$64.08 M(-25.0%) |
| Sept 2016 | - | -$85.44 M(-8.9%) |
| June 2016 | - | -$93.78 M(-177.6%) |
| Mar 2016 | - | $120.82 M(-1589.9%) |
| Dec 2015 | -$8.11 M(-105.0%) | -$8.11 M(-104.2%) |
| Sept 2015 | - | $194.07 M(+8.6%) |
| June 2015 | - | $178.78 M(+3.0%) |
| Mar 2015 | - | $173.56 M(+6.9%) |
| Dec 2014 | $162.38 M(-4101.5%) | $162.38 M(-9.8%) |
| Sept 2014 | - | $180.09 M(+1707.4%) |
| June 2014 | - | $9.96 M(-19.6%) |
| Mar 2014 | - | $12.40 M(-405.5%) |
| Dec 2013 | -$4.06 M(-65.1%) | -$4.06 M(-74.4%) |
| Sept 2013 | - | -$15.83 M(-12.1%) |
| June 2013 | - | -$18.00 M(+17.8%) |
| Mar 2013 | - | -$15.28 M(+31.5%) |
| Dec 2012 | -$11.62 M(+1.8%) | -$11.62 M(-6.7%) |
| Sept 2012 | - | -$12.45 M(+33.5%) |
| June 2012 | - | -$9.32 M(+154.6%) |
| Mar 2012 | - | -$3.66 M(-67.9%) |
| Dec 2011 | -$11.41 M(-423.2%) | -$11.41 M(-27.0%) |
| Sept 2011 | - | -$15.64 M(+10.3%) |
| June 2011 | - | -$14.18 M(+6.8%) |
| Mar 2011 | - | -$13.27 M(-475.9%) |
| Dec 2010 | $3.53 M(-77.9%) | $3.53 M(-353.5%) |
| Sept 2010 | - | -$1.39 M(+610.7%) |
| June 2010 | - | -$196.00 K(-102.2%) |
| Mar 2010 | - | $8.95 M(-44.0%) |
| Dec 2009 | $15.99 M | $15.99 M(+133.6%) |
| Sept 2009 | - | $6.85 M(-67.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $21.27 M(+43.6%) |
| Mar 2009 | - | $14.81 M(-36.5%) |
| Dec 2008 | $23.32 M(-60.5%) | $23.32 M(-32.0%) |
| Sept 2008 | - | $34.26 M(-33.5%) |
| June 2008 | - | $51.50 M(-10.6%) |
| Mar 2008 | - | $57.59 M(-2.4%) |
| Dec 2007 | $58.98 M(-8.9%) | $58.98 M(+5.4%) |
| Sept 2007 | - | $55.94 M(-12.8%) |
| June 2007 | - | $64.13 M(-26.7%) |
| Mar 2007 | - | $87.45 M(+35.1%) |
| Dec 2006 | $64.75 M(-163.3%) | $64.75 M(-140.0%) |
| Sept 2006 | - | -$161.89 M(+4.8%) |
| June 2006 | - | -$154.51 M(+7.5%) |
| Mar 2006 | - | -$143.69 M(+40.5%) |
| Dec 2005 | -$102.24 M(+110.8%) | -$102.24 M(-4.3%) |
| Sept 2005 | - | -$106.89 M(+1.9%) |
| June 2005 | - | -$104.94 M(+24.2%) |
| Mar 2005 | - | -$84.52 M(+74.2%) |
| Dec 2004 | -$48.51 M(+186.5%) | -$48.51 M(-190.2%) |
| Sept 2004 | - | $53.80 M(-6.2%) |
| June 2004 | - | $57.34 M(-15.2%) |
| Mar 2004 | - | $67.64 M(-499.6%) |
| Dec 2003 | -$16.93 M(-131.8%) | -$16.93 M(-128.4%) |
| Sept 2003 | - | $59.57 M(+173.0%) |
| June 2003 | - | $21.82 M(-13.4%) |
| Mar 2003 | - | $25.19 M(-52.7%) |
| Dec 2002 | $53.22 M(+143.6%) | $53.22 M(+157.6%) |
| Sept 2002 | - | $20.66 M(-30.1%) |
| June 2002 | - | $29.54 M(-208.7%) |
| Mar 2002 | - | -$27.16 M(-224.3%) |
| Dec 2001 | $21.85 M(+34.6%) | $21.85 M(-19.1%) |
| Sept 2001 | - | $27.00 M(-16.0%) |
| June 2001 | - | $32.13 M(-7.6%) |
| Mar 2001 | - | $34.76 M(+114.1%) |
| Dec 2000 | $16.23 M(-54.9%) | $16.23 M(-24.8%) |
| Sept 2000 | - | $21.58 M(-30.7%) |
| June 2000 | - | $31.13 M(-13.6%) |
| Mar 2000 | - | $36.02 M(+0.1%) |
| Dec 1999 | $36.00 M(-29.5%) | $36.00 M(+1.4%) |
| Sept 1999 | - | $35.50 M(+51.7%) |
| June 1999 | - | $23.40 M(-38.9%) |
| Mar 1999 | - | $38.30 M(-25.0%) |
| Dec 1998 | $51.10 M(-18.1%) | $51.10 M(+87.2%) |
| Sept 1998 | - | $27.30 M(-16.3%) |
| June 1998 | - | $32.60 M(-33.9%) |
| Mar 1998 | - | $49.30 M(-21.0%) |
| Dec 1997 | $62.40 M(-12.8%) | $62.40 M(+46.5%) |
| Sept 1997 | - | $42.60 M(-17.0%) |
| June 1997 | - | $51.30 M(-18.4%) |
| Mar 1997 | - | $62.90 M(-12.2%) |
| Dec 1996 | $71.60 M(+25.0%) | $71.60 M(+79.9%) |
| Sept 1996 | - | $39.80 M(-15.1%) |
| June 1996 | - | $46.90 M(-14.7%) |
| Mar 1996 | - | $55.00 M(-4.0%) |
| Dec 1995 | $57.30 M(+71.0%) | $57.30 M(-9.2%) |
| Sept 1995 | - | $63.10 M(+92.4%) |
| Mar 1995 | - | $32.80 M(-2.1%) |
| Dec 1994 | $33.50 M | $33.50 M(-15.6%) |
| Sept 1994 | - | $39.70 M(+51.5%) |
| June 1994 | - | $26.20 M(-21.8%) |
| Mar 1994 | - | $33.50 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual working capital?
- What is the all time high annual working capital for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual working capital year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly working capital?
- What is the all time high quarterly working capital for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly working capital year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual working capital?
The current annual working capital of LGND is $220.65 M
What is the all time high annual working capital for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual working capital is $1.11 B
What is Ligand Pharmaceuticals Incorporated annual working capital year-on-year change?
Over the past year, LGND annual working capital has changed by +$55.86 M (+33.90%)
What is Ligand Pharmaceuticals Incorporated quarterly working capital?
The current quarterly working capital of LGND is $284.62 M
What is the all time high quarterly working capital for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly working capital is $1.38 B
What is Ligand Pharmaceuticals Incorporated quarterly working capital year-on-year change?
Over the past year, LGND quarterly working capital has changed by +$46.35 M (+19.45%)